Boston Scientific Corp

US

BSX

Health Care

68.02 ₽

Current price

Hold
68.02 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    159 / 663

  • Position in country

    3148 / 14179

  • Return on Assets, %

    4.7

    -11.9

  • Net income margin, %

    13.5

    -12.5

  • EBITDA margin, %

    24.9

    -2.5

  • Debt to Equity, %

    47.2

    15

  • Intangible assets and goodwill, %

    58

    3.9

  • Revenue CAGR 3Y, %

    12.8

    12.6

  • Total Equity change 1Y, %

    9.7

    0

  • Revenue Y, % chg

    12.2

    4.6

  • P/E

    63.5

    28.3

  • P/BV

    5.1

    1.7

  • P/S

    7

    3.7

  • EV/S

    7.6

    3.2

  • EV/EBITDA

    26.6

    -0.2

  • Average Analyst recommendation

    Buy

    Buy

  • Average upside forecasts, %

    5.7

    66.5

  • Forward P/E

    29.1

    19.2

  • Expected dividend per share

    0

    0

  • Payout Ratio, %

    0

    17.3

Get an analytical review of this company

Competitors

Ranks

  • Dexcom Inc

    00%

  • Boston Scientific Corp

    00%

  • Intuitive Surgical Inc

    00%

  • Stryker Corp

    00%

  • Edwards Lifesciences Corp

    00%

  • IDEXX Laboratories Inc

    00%

  • Resmed Inc

    00%

  • Abbott Laboratories

    00%

  • GE Healthcare Technologies Inc

    00%

  • Becton Dickinson and Co

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    United States of America

  • Sector

    Health Care

  • Industry group

    Health Care Equipment & Services

  • Industry

    Health Care Equipment & Supplies

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    100055.7

  • Ticker

    BSX.N

  • ISIN

    US1011371077

  • IPO date

    1992-05-19

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-02-20

  • Date fact. publication of reports

    2023-12-31

Company Description

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by businesses such Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. It operates in three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. MedSurg consists of Endoscopy and Urology and Pelvic Health businesses. Rhythm segment consists of Cardiac Rhythm Management, Electrophysiology and Neuromodulation businesses. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Its product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.